Company / Net Income
Baxter International Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$957.0M
FY2025
5-year range
-$2.4B / $2.7B
FY2021-FY2025
Trend
-47.5%
vs FY2024
Sector context
#160 of 164
Health Care
What the data says
Among 164 Health Care companies, Baxter International is in the bottom 2% for net income. Net Income has fluctuated over the past 10 years, ranging from -$2.4B in FY2022 to $2.7B in FY2023.
Based on SEC 10-K filings.
-$957M in FY2025.
Declined from $2.7B to -$957M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 164This company -$957.0M Sector average $467.2M
▼
-304.8% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 47.5% year-over-year.
- Ranks #160 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2023.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$957.0M | -47.5% |
| FY2024 | -$649.0M | -124.4% |
| FY2023 | $2.7B | +209.2% |
| FY2022 | -$2.4B | -289.5% |
| FY2021 | $1.3B | +16.5% |
| FY2020 | $1.1B | +83.1% |
| FY2019 | $602.0M | -61.1% |
| FY2018 | $1.5B | +156.8% |
| FY2017 | $602.0M | -75.9% |
| FY2016 | $2.5B | +158.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026